The biology and pathogenicity of Clostridium perfringens type F: a common human enteropathogen with a new(ish) name Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

February 14, 2026

  • Microbes
    Microbes

    Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2026-02-14

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was reviewed?

This review examined the microbiology, genomics, toxin production, sporulation biology, environmental persistence, and microbiome-associated pathogenic mechanisms of Clostridium perfringens type F, a major human enteropathogen responsible for food poisoning and antibiotic-associated diarrhea. The authors analyzed how type F strains, defined by carriage of the enterotoxin gene (cpe) and alpha toxin gene, use sporulation-dependent enterotoxin production, plasmid or chromosomal virulence gene carriage, and microbiome colonization strategies to induce gastrointestinal disease. The review explained that pathogenicity depends on enterotoxin-mediated epithelial injury, sporulation-triggered toxin release, and environmental resilience through spore formation, allowing survival in food and the gastrointestinal microbiome. These mechanisms enable type F strains to transition from environmental or microbiome commensals into toxin-producing pathogens capable of rapid expansion and epithelial barrier disruption in the human intestine.

Who was reviewed?

The review synthesized microbiological, genomic, clinical, and experimental studies involving Clostridium perfringens type F isolates obtained from human gastrointestinal microbiomes, foodborne outbreak samples, environmental reservoirs, and animal infection models. These studies included isolates carrying chromosomal cpe genes associated with food poisoning and plasmid-borne cpe genes associated with antibiotic-associated diarrhea and sporadic gastrointestinal disease. Human clinical studies demonstrated detection of enterotoxin and toxin-producing strains in stool samples of infected patients, while genomic and experimental investigations analyzed toxin production, sporulation, microbiome colonization, and host epithelial damage mechanisms. Environmental surveys and microbiome carriage studies confirmed that type F strains exist in soil, sewage, food products, and healthy human microbiomes, demonstrating their widespread presence and opportunistic pathogenic potential.

What were the most important findings?

The most important finding was that Clostridium perfringens type F pathogenicity depends on sporulation-triggered production and release of Clostridium perfringens enterotoxin (CPE), which binds intestinal epithelial claudin receptors, forms membrane pores, and disrupts epithelial barrier integrity, causing diarrhea, inflammation, and fluid loss. Major microbial associations included microbiome colonization followed by sporulation within the intestine, toxin release during mother cell lysis, and enterotoxin-mediated epithelial injury. CPE binds claudin-3 and claudin-4 receptors on intestinal epithelial cells, oligomerizes into prepore complexes, and inserts into membranes to form pores that allow calcium influx, activating apoptosis or necroptosis and causing epithelial damage.

The review also showed that sporulation is essential for toxin production, as the cpe gene is activated by sporulation-specific sigma factors and regulatory kinases that initiate toxin expression. Microbiome persistence and transmission are enhanced by highly resistant spores, which can survive extreme heat, disinfectants, and environmental stress, allowing contamination of food and persistence in host microbiomes. Additionally, accessory virulence factors such as NanH sialidase promote intestinal colonization and enhance toxin activity by modifying host glycans. Genomic analysis demonstrated that toxin genes are carried on transferable plasmids or chromosomal loci, enabling horizontal gene transfer and rapid evolution of virulence within microbiome populations. These findings confirm that microbiome colonization, sporulation-dependent toxin production, and epithelial receptor targeting collectively drive disease pathogenesis.

What are the greatest implications of this review?

This review demonstrated that Clostridium perfringens type F functions as a microbiome-associated opportunistic pathogen whose virulence depends on sporulation-dependent enterotoxin production, microbiome colonization, and toxin-mediated epithelial barrier disruption. The ability of type F strains to persist in microbiomes, survive environmental stress through spore formation, and rapidly activate toxin production in the intestine makes them a major cause of foodborne and antibiotic-associated gastrointestinal disease. These findings emphasize the importance of microbiome stability, early detection of toxin-producing strains, and prevention of spore contamination in food and clinical environments. Clinicians should recognize that toxin production, microbiome ecology, and sporulation regulation determine disease risk, highlighting microbiome-targeted prevention, toxin diagnostics, and antimicrobial stewardship as key strategies to reduce gastrointestinal infection and improve patient outcomes.

Clostridium perfringens

Clostridium perfringens is a fast-growing, Gram-positive, spore-forming anaerobe and a major toxin-mediated pathogen affecting humans and animals. Widely distributed in soil, food, and gastrointestinal microbiota, it causes diseases ranging from food poisoning and antibiotic-associated diarrhoea to life-threatening clostridial myonecrosis. Its pathogenicity is driven by diverse plasmid-encoded toxins, including α-toxin, enterotoxin, and perfringolysin O, while conjugative mobile genetic elements facilitate rapid dissemination of antimicrobial resistance and virulence traits. Genome-informed toxinotyping and molecular surveillance are therefore essential for accurate risk assessment, clinical management, and outbreak control.

Major Microbial Associations (MMAs)

Major Microbial Associations (MMAs) are fundamental in understanding disease-microbiome interactions and play a crucial role in advancing microbiome-targeted interventions aimed at treating or preventing diseases through microbial modulation.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.